Statistical properties of methods based on the Q-statistic for constructing a confidence interval for the between-study variance in meta-analysis

Robbie C. M. van Aert*, Marcel A. L. M. van Assen, Wolfgang Viechtbauer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The effect sizes of studies included in a meta-analysis do often not share a common true effect size due to differences in for instance the design of the studies. Estimates of this so-called between-study variance are usually imprecise. Hence, reporting a confidence interval together with a point estimate of the amount of between-study variance facilitates interpretation of the meta analytic results. Two methods that are recommended to be used for creating such a confidence interval are the Q-profile and generalized Q-statistic method that both make use of the Q-statistic. These methods are exact if the assumptions underlying the random-effects model hold, but these assumptions are usually violated in practice such that confidence intervals of the methods are approximate rather than exact confidence intervals. We illustrate by means of two Monte-Carlo simulation studies with odds ratio as effect size measure that coverage probabilities of both methods can be substantially below the nominal coverage rate in situations that are representative for meta-analyses in practice. We also show that these too low coverage probabilities are caused by violations of the assumptions of the random-effects model (ie, normal sampling distributions of the effect size measure and known sampling variances) and are especially prevalent if the sample sizes in the primary studies are small.

Original languageEnglish
Pages (from-to)225-239
Number of pages15
JournalResearch Synthesis Methods
Volume10
Issue number2
DOIs
Publication statusPublished - Jun 2019

Keywords

  • confidence intervals
  • heterogeneity
  • meta-analysis
  • random-effects model
  • MOMENT-BASED ESTIMATORS
  • RANDOM-EFFECTS MODEL
  • CLINICAL-TRIALS
  • HETEROGENEITY
  • FRAMEWORK

Cite this